Authors: Fagan, TC Buttler, S Marbury, T Taylor, A Edmonds, A

Citation: Tc. Fagan et al., Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates, AM J CARD, 88(7), 2001, pp. 760-766

Authors: Littlejohn, T Mroczek, W Marbury, T VanderMaelen, CP Dubiel, RF

Citation: T. Littlejohn et al., A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring, CAN J CARD, 16(9), 2000, pp. 1123-1132

Authors: Mazzu, AL Lettieri, JT Kelly, E Vargas, R Marbury, T Liu, MC Sundaresan, P

Citation: Al. Mazzu et al., Influence of renal function on the pharmacokinetics of cerivastatin in normocholesterolemic adults, EUR J CL PH, 56(1), 2000, pp. 69-74

Authors: Littlejohn, T Saini, R Kassler-Taub, K Crysant, SG Marbury, T

Citation: T. Littlejohn et al., Long-term safety and antihypertensive efficacy of irbesartan: Pooled results of five open-label studies, CLIN EXP HY, 21(8), 1999, pp. 1273-1295

Authors: Marbury, T Huang, WC Strange, P Lebovitz, H

Citation: T. Marbury et al., Repaglinide versus glyburide: a one-year comparison trial, DIABET RE C, 43(3), 1999, pp. 155-166

Authors: Dorr, MB Johnson, RD Jensen, B Magner, D Marbury, T Talbo, GH

Citation: Mb. Dorr et al., Pharmacokinetics of sparfloxacin in patients with renal impairment, CLIN THER, 21(7), 1999, pp. 1202-1215